Omitting the Escalating Dosage of Alpha-adrenergic Blockade Before Pheochromocytoma Resection: Implementation of a Treatment Strategy in Discordance With Current Guidelines.

MLA

Holscher, Isabelle, et al. “Omitting the Escalating Dosage of Alpha-Adrenergic Blockade Before Pheochromocytoma Resection: Implementation of a Treatment Strategy in Discordance With Current Guidelines.” Annals of Surgery, vol. 280, no. 5, Nov. 2024, pp. 817–24. EBSCOhost, https://doi.org/10.1097/SLA.0000000000006493.

APA

Holscher, I., Engelsman, A. F., Dreijerink, K. M. A., Hollmann, M. W., van den Berg, T. J., & Nieveen van Dijkum, E. J. M. (2024). Omitting the Escalating Dosage of Alpha-adrenergic Blockade Before Pheochromocytoma Resection: Implementation of a Treatment Strategy in Discordance With Current Guidelines. Annals of Surgery, 280(5), 817–824. https://doi.org/10.1097/SLA.0000000000006493

Chicago

Holscher, Isabelle, Anton F Engelsman, Koen M A Dreijerink, Markus W Hollmann, Tijs J van den Berg, and Els J M Nieveen van Dijkum. 2024. “Omitting the Escalating Dosage of Alpha-Adrenergic Blockade Before Pheochromocytoma Resection: Implementation of a Treatment Strategy in Discordance With Current Guidelines.” Annals of Surgery 280 (5): 817–24. doi:10.1097/SLA.0000000000006493.